These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

175 related articles for article (PubMed ID: 28750921)

  • 1. The methodology of surveillance for antimicrobial resistance and healthcare-associated infections in Europe (SUSPIRE): a systematic review of publicly available information.
    Núñez-Núñez M; Navarro MD; Palomo V; Rajendran NB; Del Toro MD; Voss A; Sharland M; Sifakis F; Tacconelli E; Rodríguez-Baño J;
    Clin Microbiol Infect; 2018 Feb; 24(2):105-109. PubMed ID: 28750921
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Surveillance Systems from Public Health Institutions and Scientific Societies for Antimicrobial Resistance and Healthcare-Associated Infections in Europe (SUSPIRE): protocol for a systematic review.
    Núñez-Núñez M; Navarro MD; Gkolia P; Babu Rajendran N; Del Toro MD; Voss A; Sharland M; Sifakis F; Tacconelli E; Rodríguez-Baño J;
    BMJ Open; 2017 Mar; 7(3):e014538. PubMed ID: 28348192
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Burden of Six Healthcare-Associated Infections on European Population Health: Estimating Incidence-Based Disability-Adjusted Life Years through a Population Prevalence-Based Modelling Study.
    Cassini A; Plachouras D; Eckmanns T; Abu Sin M; Blank HP; Ducomble T; Haller S; Harder T; Klingeberg A; Sixtensson M; Velasco E; Weiß B; Kramarz P; Monnet DL; Kretzschmar ME; Suetens C
    PLoS Med; 2016 Oct; 13(10):e1002150. PubMed ID: 27755545
    [TBL] [Abstract][Full Text] [Related]  

  • 4. NHSN annual update: antimicrobial-resistant pathogens associated with healthcare-associated infections: annual summary of data reported to the National Healthcare Safety Network at the Centers for Disease Control and Prevention, 2006-2007.
    Hidron AI; Edwards JR; Patel J; Horan TC; Sievert DM; Pollock DA; Fridkin SK; ;
    Infect Control Hosp Epidemiol; 2008 Nov; 29(11):996-1011. PubMed ID: 18947320
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Implementation of infection prevention and control in acute care hospitals in Mainland China - a systematic review.
    Wang J; Liu F; Tan JBX; Harbarth S; Pittet D; Zingg W
    Antimicrob Resist Infect Control; 2019; 8():32. PubMed ID: 30792854
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Device-associated infection rates, device utilization, and antimicrobial resistance in long-term acute care hospitals reporting to the National Healthcare Safety Network, 2010.
    Chitnis AS; Edwards JR; Ricks PM; Sievert DM; Fridkin SK; Gould CV
    Infect Control Hosp Epidemiol; 2012 Oct; 33(10):993-1000. PubMed ID: 22961018
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Epidemiology of device-associated infections in an intensive care unit of a teaching hospital in Nepal: A prospective surveillance study from a developing country.
    Parajuli NP; Acharya SP; Dahal S; Singh JP; Mishra SK; Kattel HP; Rijal BP; Pokhrel BM
    Am J Infect Control; 2017 Sep; 45(9):1024-1029. PubMed ID: 28431848
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The European Centre for Disease Prevention and Control (ECDC) pilot point prevalence survey of healthcare-associated infections and antimicrobial use.
    Zarb P; Coignard B; Griskeviciene J; Muller A; Vankerckhoven V; Weist K; Goossens M; Vaerenberg S; Hopkins S; Catry B; Monnet D; Goossens H; Suetens C; ;
    Euro Surveill; 2012 Nov; 17(46):. PubMed ID: 23171822
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Surveillance of device-associated infection rates and mortality in 3 Greek intensive care units.
    Apostolopoulou E; Raftopoulos V; Filntisis G; Kithreotis P; Stefanidis E; Galanis P; Veldekis D
    Am J Crit Care; 2013 May; 22(3):e12-20. PubMed ID: 23635940
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Guidance on public reporting of healthcare-associated infections: recommendations of the Healthcare Infection Control Practices Advisory Committee.
    McKibben L; Horan T; Tokars JI; Fowler G; Cardo DM; Pearson ML; Brennan PJ;
    Am J Infect Control; 2005 May; 33(4):217-26. PubMed ID: 15877016
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Systematic literature review of the burden and outcomes of infections due to multidrug-resistant organisms in Europe: the ABOUT-MDRO project protocol.
    Anaya-Baz B; Maldonado N; Palacios-Baena ZR; Palomo V; Pezzani MD; Chiesi S; Razzaboni E; Compri M; Tacconelli E; Rodriguez-Baño J
    BMJ Open; 2020 May; 10(5):e030608. PubMed ID: 32371505
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Surveillance of healthcare associated infections, bacterial resistance and antibiotic consumption in high-complexity hospitals in Colombia, 2011].
    Villalobos AP; Barrero LI; Rivera SM; Ovalle MV; Valera D
    Biomedica; 2014 Apr; 34 Suppl 1():67-80. PubMed ID: 24968038
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Incidence, Microbiological Profile and Risk Factors of Healthcare-Associated Infections in Intensive Care Units: A 10 Year Observation in a Provincial Hospital in Southern Poland.
    Kołpa M; Wałaszek M; Gniadek A; Wolak Z; Dobroś W
    Int J Environ Res Public Health; 2018 Jan; 15(1):. PubMed ID: 29324651
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Device-associated nosocomial infections in limited-resources countries: findings of the International Nosocomial Infection Control Consortium (INICC).
    Rosenthal VD
    Am J Infect Control; 2008 Dec; 36(10):S171.e7-12. PubMed ID: 19084148
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Device-associated infections in the pediatric intensive care unit at the American University of Beirut Medical Center.
    Ismail A; El-Hage-Sleiman AK; Majdalani M; Hanna-Wakim R; Kanj S; Sharara-Chami R
    J Infect Dev Ctries; 2016 Jun; 10(6):554-62. PubMed ID: 27367002
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Longitudinal trends in all healthcare-associated infections through comprehensive hospital-wide surveillance and infection control measures over the past 12 years: substantial burden of healthcare-associated infections outside of intensive care units and "other" types of infection.
    Kanamori H; Weber DJ; DiBiase LM; Sickbert-Bennett EE; Brooks R; Teal L; Williams D; Walters EM; Rutala WA
    Infect Control Hosp Epidemiol; 2015 Oct; 36(10):1139-47. PubMed ID: 26108686
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prevalence of healthcare-associated infections in Polish adult intensive care units: summary data from the ECDC European Point Prevalence Survey of Hospital-associated Infections and Antimicrobial Use in Poland 2012-2014.
    Deptuła A; Trejnowska E; Dubiel G; Żukowski M; Misiewska-Kaczur A; Ozorowski T; Hryniewicz W
    J Hosp Infect; 2017 Jun; 96(2):145-150. PubMed ID: 28173962
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Review of antimicrobial resistance surveillance programmes in livestock and meat in EU with focus on humans.
    Schrijver R; Stijntjes M; Rodríguez-Baño J; Tacconelli E; Babu Rajendran N; Voss A
    Clin Microbiol Infect; 2018 Jun; 24(6):577-590. PubMed ID: 28970159
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical outcomes of health-care-associated infections and antimicrobial resistance in patients admitted to European intensive-care units: a cohort study.
    Lambert ML; Suetens C; Savey A; Palomar M; Hiesmayr M; Morales I; Agodi A; Frank U; Mertens K; Schumacher M; Wolkewitz M
    Lancet Infect Dis; 2011 Jan; 11(1):30-8. PubMed ID: 21126917
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.